179 related articles for article (PubMed ID: 28939130)
121. Immunophenotype of T Cells Expressing Programmed Death-1 and Cytotoxic T Cell Antigen-4 in Early Lung Cancer: Local vs. Systemic Immune Response.
Kwiecien I; Skirecki T; Polubiec-Kownacka M; Raniszewska A; Domagala-Kulawik J
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31010080
[TBL] [Abstract][Full Text] [Related]
122. Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients.
Saavedra D; García B; Lorenzo-Luaces P; González A; Popa X; Fuentes KP; Mazorra Z; Crombet T; Neninger E; Lage A
Cancer Immunol Immunother; 2016 Jan; 65(1):37-45. PubMed ID: 26589409
[TBL] [Abstract][Full Text] [Related]
123. Role of lymphocyte subsets and IL-17 in non-small cell lung cancer.
Deng C; Ren BY; Huang XP; Tan JJ; Wu JJ; Wang W; Zhu C
J Biol Regul Homeost Agents; 2020; 34(2):319-326. PubMed ID: 32431141
[No Abstract] [Full Text] [Related]
124. Increased percentage of apoptotic and CTLA-4 (CD152) expressing cells in CD4+/CD8+ cells in COVID-19 patients.
Zahran AM; Nafady-Hego H; Rashad A; El-Badawy O; Nasif KA; Mostafa AT; Osman HA; Dongol EM; Hashim AA; Abdelrazek GM; Abd Elrahman NH; Nafady A
Medicine (Baltimore); 2022 Sep; 101(38):e30650. PubMed ID: 36197228
[TBL] [Abstract][Full Text] [Related]
125. Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy.
Klein O; Kee D; Markman B; Carlino MS; Underhill C; Palmer J; Power D; Cebon J; Behren A
Cancer Cell; 2021 May; 39(5):592-593. PubMed ID: 33930312
[No Abstract] [Full Text] [Related]
126. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells.
Reiss S; Baxter AE; Cirelli KM; Dan JM; Morou A; Daigneault A; Brassard N; Silvestri G; Routy JP; Havenar-Daughton C; Crotty S; Kaufmann DE
PLoS One; 2017; 12(10):e0186998. PubMed ID: 29065175
[TBL] [Abstract][Full Text] [Related]
127. Comment on "Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells".
Ghebeh H; Dermime S
J Immunol; 2007 Jul; 179(2):732; author reply 733. PubMed ID: 17617559
[No Abstract] [Full Text] [Related]
128. Clinical predictive value of naïve and memory T cells in advanced NSCLC.
Zhang G; Liu A; Yang Y; Xia Y; Li W; Liu Y; Zhang J; Cui Q; Wang D; Liu X; Guo Y; Chen H; Yu J
Front Immunol; 2022; 13():996348. PubMed ID: 36119064
[TBL] [Abstract][Full Text] [Related]
129. Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer.
Zhang T; Yu H; Ni C; Zhang T; Liu L; Lv Q; Zhang Z; Wang Z; Wu D; Wu P; Chen G; Wang L; Wei Q; Huang J; Wang X
Sci Rep; 2017 Jul; 7(1):4866. PubMed ID: 28687760
[TBL] [Abstract][Full Text] [Related]
130. Effects of interleukin-2 immunotherapy on soluble lymphocyte markers in cancer patients.
Lissoni P; Rovelli F; Tisi E; Ballabio D; Benenti C; Ardizzoia A; Barni S; Tancini B
Int J Biol Markers; 1992; 7(4):260-2. PubMed ID: 1337089
[No Abstract] [Full Text] [Related]
131. Peripheral Polyfunctional PD1
Liu Y; Lu P; Ma Y; Yin Z; Xu H; Xiang L; Zhang W; Li S; Liang X
Eur J Immunol; 2022 Aug; 52(8):1369-1371. PubMed ID: 35689391
[TBL] [Abstract][Full Text] [Related]
132. [Immunological Effect of Hydrogen Gas-Hydrogen Gas Improves Clinical Outcomes of Cancer Patients].
Akagi J
Gan To Kagaku Ryoho; 2018 Oct; 45(10):1475-1478. PubMed ID: 30382050
[TBL] [Abstract][Full Text] [Related]
133. Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics.
Arasanz H; Zuazo M; Bocanegra A; Gato M; Martínez-Aguillo M; Morilla I; Fernández G; Hernández B; López P; Alberdi N; Hernández C; Chocarro L; Teijeira L; Vera R; Kochan G; Escors D
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033028
[TBL] [Abstract][Full Text] [Related]
134. At the Checkpoint: Lung CD8(+) T Cells, Respiratory Viruses, and Chronic Obstructive Pulmonary Disease.
Curtis JL
Am J Respir Crit Care Med; 2016 Mar; 193(6):600-2. PubMed ID: 26977966
[No Abstract] [Full Text] [Related]
135. Radiochemotherapy upregulates expression of checkpoint receptors on circulating T cells.
Li D; Guan Y; Dong Y; Wu J; Zhang Y; Chen R; Lin YT; Fornace AJ; Li HH; Yuan Z
Int J Radiat Biol; 2021; 97(11):1563-1568. PubMed ID: 34402381
[TBL] [Abstract][Full Text] [Related]
136. Cognitive impairment is related to a reduced count of T-lymphocytes in older patients diagnosed with non-small cell lung cancer (NSCLC).
Soria-Comes T; Palomar-Abril V; Martín Ureste M; García Sánchez J; Marco Buades JE; Fernández Llavador MJ; López Gabaldón A; González Jurado M; Maestu Maiques IC
Transl Cancer Res; 2020 Nov; 9(11):6857-6866. PubMed ID: 35117294
[TBL] [Abstract][Full Text] [Related]
137. Elevated peripheral blood B lymphocytes and CD3
Liang H; Chu X; Zhao J; Xing G; Si Y
Oncol Lett; 2018 Jun; 15(6):8387-8395. PubMed ID: 29805573
[TBL] [Abstract][Full Text] [Related]
138. Checkpoint Inhibitors in Lung Cancer Are Not Immune from Cost-Effectiveness Analysis.
Kelly RJ; Smith TJ
J Thorac Oncol; 2016 Nov; 11(11):1814-1816. PubMed ID: 27770973
[No Abstract] [Full Text] [Related]
139. Expression of surface lymphocyte markers in various courses of gastrointestinal tumors.
Oleinik EK; Shibaev MI; Oleinik VM
Bull Exp Biol Med; 2004 Apr; 137(4):385-8. PubMed ID: 15452610
[TBL] [Abstract][Full Text] [Related]
140. LAG-3: a very singular immune checkpoint.
Lui Y; Davis SJ
Nat Immunol; 2018 Dec; 19(12):1278-1279. PubMed ID: 30446753
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
